Guide price only. Final cost is confirmed after assessment.
At London Cartilage Clinic, we specialise in utilising Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) for the regeneration and repair of cartilage. MSCs represent a breakthrough in non-invasive cartilage therapy, offering an effective alternative to traditional surgical methods. Our focus is on harnessing these cells' innate ability to repair and regenerate cartilage tissue, thus improving joint function and reducing discomfort.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
MSCs are particularly effective in cartilage regeneration due to their ability to differentiate into chondrocytes, the cells that form cartilage. This capacity makes them instrumental in treating conditions like osteoarthritis, where cartilage deterioration is a major concern. By administering MSCs directly into the affected joints, we facilitate the natural repair of cartilage, offering patients improved mobility and pain relief.
Our clinic’s approach involves extracting MSCs from the patient, process them and then reinjecting them into the affected cartilage area. This process not only stimulates the natural regeneration of cartilage but also reduces the need for invasive surgeries. Patients benefit from a minimally invasive procedure with a shorter recovery period and long-lasting improvements in joint function.
MSC therapy is highly effective in treating cartilage-related conditions such as osteoarthritis, sports injuries, and cartilage degeneration. By focusing on the repair and regeneration of cartilage, this therapy offers a promising alternative for those seeking relief from joint pain and mobility issues.
Stem Cell / Medicinal Signaling Cell therapy for cartilage repair offers several benefits over traditional surgical methods. It is a minimally invasive procedure that can reduce recovery time, decrease the risk of complications, and provide a more natural regeneration of cartilage. This therapy is particularly effective in treating conditions like osteoarthritis, offering patients an opportunity to improve joint function and reduce pain.
At London Cartilage Clinic, we are at the forefront of Stem Cell / Medicinal Signaling Cell research and its application in orthopaedic medicine. Our team of specialists is highly experienced in Stem Cell / Medicinal Signaling Cell therapies, ensuring that you receive the most advanced and effective treatment. We are committed to providing personalised care and achieving the best possible outcomes for our patients.
MSC therapy has shown significant effectiveness in regenerating damaged cartilage. It promotes the repair of cartilage tissue, offering an innovative solution for conditions like osteoarthritis and other cartilage-related injuries.
MSCs are uniquely capable of direct and give the correct signal for chondrocytes, the cells responsible for forming cartilage. This makes them particularly suitable for repairing and regenerating damaged cartilage tissues. It is important to understand that MSC does not directly turns into cartilage, but they gives important signals for exiting cartilage cells to regenerate.
MSC therapy is generally safe with minimal side effects, as it uses the patient’s own cells. This reduces the risks of adverse reactions, making it a safe option for cartilage repair.
In many cases, MSC therapy can delay or even prevent the need for joint replacement surgery by effectively regenerating damaged cartilage and restoring joint function.
Stem Cell / Medicinal Signaling Cell cartilage repair is a promising option for many patients, but suitability depends on individual circumstances, including the extent of cartilage damage and overall health. A consultation with our specialists can determine if this treatment is right for you.
Recovery times can vary, but many patients experience a quicker return to normal activities compared to traditional surgery. The minimally invasive nature of the procedure often results in less pain and faster healing.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
ChondroFiller is an injectable collagen scaffold that prompts the patient's own progenitor cells to regenerate cartilage defects; it holds CE Class III approval, and published prospective data document functional improvements of approximately 30 points sustained at three-year follow-up.
An unloader brace applies a corrective force that opens the medial joint space and shifts body weight toward the lateral compartment. Pain relief is not symptom masking but reflects the resulting reduction in mechanical stress on damaged cartilage.
Walking safety after a torn meniscus depends on tear stability, not pain: stable degenerative tears tolerate controlled weight-bearing, whilst unstable fragments risk progressive damage.
